Skip to main content
  1. Home

Spring 2024

Valid for Measure Submission
✔

Bloodstream Infection in Hemodialysis Outpatients

  • Annual standardized infection ratio (SIR) of bloodstream infections (BSIs) among children and adults receiving maintenance hemodialysis at outpatient hemodialysis facilities. BSIs are defined as positive blood cultures for hemodialysis patients which are reported monthly by participating facilities. The SIR is reported for a yearly period (calendar year) and is calculated by dividing the number of observed BSIs by the number of predicted BSIs during the year.

    CBE ID
    1460

Continuity of Care After Inpatient or Residential Treatment for Substance Use Disorder

  • The Continuity of Care After Inpatient or Residential Treatment for Substance Use Disorder measure evaluates the percentage of discharges from inpatient or residential treatment for diagnoses of substance use disorders (SUD) among Medicaid or Medicare-Medicaid beneficiaries, aged 18 years and older, which were followed by a treatment service for SUD.

    CBE ID
    3453

E&M Educational Webinar: Enhancements to the Endorsement and Maintenance (E&M) Process for the Spring 2024 Cycle

Beginning with the Fall 2023 E&M cycle, measure developers and stewards submitted measures to Battelle for PQM endorsement review. We appreciate the participation and engagement of all interested parties during the Fall 2023 cycle, including E&M committee members, developers, stewards, and members of the public.

In response to recent feedback received from E&M committee members and measure developers/stewards regarding the Fall 2023 cycle, we seek to implement several changes to the E&M committee roles, voting, and meeting structure. 

E&M Spring 2024 Advanced Illness and Post- Acute Care Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

E&M Spring 2024 Cost and Efficiency Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

E&M Spring 2024 Initial Recognition Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

E&M Spring 2024 Management of Acute and Chronic Events Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

E&M Spring 2024 Primary Prevention Endorsement Meeting

The purpose of this meeting is for Recommendation Group members to discuss and share perspectives regarding the measures under endorsement review for their respective E&M committee. Endorsement voting occurs during these virtual meetings. Advisory Group members are invited to attend these Recommendation Group meetings to listen to the discussion. Measure developers/stewards are invited and encouraged to attend, as they will have the opportunity to respond to the Recommendation Group discussion during the meeting.

Facility 7-Day Risk-Standardized Hospital Visit Rate after Outpatient Colonoscopy

  • This measure was developed to improve the quality of care delivered to patients undergoing outpatient colonoscopy procedures. The Facility 7-Day Risk-Standardized Hospital Visit Rate after Outpatient Colonoscopy Measure, estimates a facility-level rate of risk-standardized, all-cause, unplanned hospital visits within seven days of a colonoscopy procedure performed at a hospital outpatient department (HOPD) or ambulatory surgical center (ASC) among Medicare Fee-for-Service (FFS) patients aged 65 years and older.

    CBE ID
    2539